Stock Events

Stock Events

Cadrenal Therapeutics (CVKD) Q2 2025 Earnings

8MayConfirmed

Q3 2024

Q4 2024

Q1 2025

Q2 2025

-2.25

-1.93

-1.6

-1.28

Details

Expected EPS

-2.15

Actual EPS

-2.09

Surprise EPS

0.06

Surprise Percent

+2.79%

Description

Cadrenal Therapeutics (CVKD) has reported earnings of -2.09 per share for Q2 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.